Evidence map›Paper›PMID 34659433›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Antiviral Effect of Hyunggaeyungyo-Tang on A549 Cells Infected with Human Coronavirus.

Seo-Young Won, In-Chan Seol, Ho-Ryong Yoo, Yoon-Sik Kim

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Pharmaceutical biology · 2025
    Article
  3. Antiviral Effect of Hyunggaeyungyo-Tang on A549 Cells Infected with Human Coronavirus.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Seo-Young WonDepartment of Korean Internal Medicine, College of Korean Medicine Daejeon University, Daejeon KS015, Republic of Korea.ORCID https://orcid.org/0000-0002-9274-5426
In-Chan SeolDepartment of Korean Internal Medicine, College of Korean Medicine Daejeon University, Daejeon KS015, Republic of Korea.ORCID https://orcid.org/0000-0001-7142-7042
Ho-Ryong YooDepartment of Korean Internal Medicine, College of Korean Medicine Daejeon University, Daejeon KS015, Republic of Korea.ORCID https://orcid.org/0000-0001-6152-7488
Yoon-Sik KimDepartment of Korean Internal Medicine, College of Korean Medicine Daejeon University, Daejeon KS015, Republic of Korea.ORCID https://orcid.org/0000-0003-4999-3288
Daejeon University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHerbal medicine is widely recommended to treat viral infectious diseases. Over 123,000,000 individuals have been infected with the coronavirus since a worldwide pandemic was declared in March 2020. We conducted this research to confirm the potential of herbal medicine as a treatment for coronavirus.

methodsWe infected the A549 cell line with betacoronavirus OC43 and then treated it with 100

resultsWe found that the effects of HYGYT decrease the expression level of pPKR, peIF2

conclusionThrough the reduction of the amount of coronavirus RNA, our research indicates that HGYGT has antiviral effects. The reduction of IKK and iNOS mRNA levels indicate that HGYGT reduces coronavirus RNA expression and may inhibit the replication of coronavirus by acting on NF-kB/Rel pathways to protect oxidative injury. In addition, decreases in mRNA expression levels of proinflammatory cytokines indicate that the HGYGT may relieve the symptoms of coronavirus infections.

Identifiers

PMID34659433
PMCPMC8514924
OpenAlexW3203476046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.